Brief: Innovative Pharmaceutical Biotech Sees Loss Attributed For HY Between Hk$110 Mln & Hk$130 Mln

Starcoin

24/11/2022 15:02

Nov 24 (Reuters) - Innovative Pharmaceutical Biotech Ltd
 0399.HK :
    * SEES LOSS ATTRIBUTED FOR SIX MONTHS IN RANGE BETWEEN
HK$110
MILLION AND HK$130 MILLION
    * EXPECTED RESULT AS NON-CASH ITEM RESULTED FROM COMPLETION
OF
MODIFICATION OF CONVERTIBLE BOND IN HY ENDED SEPT 2021

Further company coverage:  0399.HK 
 ((Reuters.Briefs@thomsonreuters.com;))